Sign Up to like & get
recommendations!
1
Published in 2020 at "Annals of Thoracic Medicine"
DOI: 10.4103/atm.atm_352_19
Abstract: BACKGROUND: Novel oral anticoagulants (NOACs) were developed as alternatives to warfarin. However, the patients' preference regarding warfarin or the NOACs has not been established. Quality-of-life (QOL) surveys are a well-established method for determining the patients'…
read more here.
Keywords:
treatment;
apixaban patient;
patient perspective;
warfarin apixaban ... See more keywords